Keyphrases
Atopic Dermatitis
100%
Management Recommendations
100%
Nondurables
100%
Dupilumab
100%
Partial Responder
33%
Novel Therapeutics
16%
Therapeutic Potential
16%
Treatment Modalities
16%
Therapeutic Algorithm
16%
Partial Loss
16%
Targeted Agents
16%
Immunosuppressive Agents
16%
Lack of Response
16%
Systemic Agents
16%
Drug pipeline
16%
Topical Therapy
16%
Investigator's Global Assessment
16%
Alternative Diagnosis
16%
Assessment Score
16%
Moderate-to-severe Atopic Dermatitis
16%
Loss of Effectiveness
16%
Atopic Dermatitis Treatment
16%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
100%
Dupilumab
100%
Drug Development
16%
Immunosuppressive Agent
16%
Medicine and Dentistry
Atopic Dermatitis
100%
Dupilumab
100%
Topical Treatment
16%
Immunosuppressive Drug
16%
Immunology and Microbiology
Atopic Dermatitis
100%
Dupilumab
100%
Immunosuppressive Drug
16%